Send to

Choose Destination
See comment in PubMed Commons below
J NeuroAIDS. 1996;1(4):1-5.

Pilot Study of Didanosine in Patients with HIV Dementia.

Author information

, Box 673, 601 Elmwood Ave, Rochester, NY, 14642, UNITED STATES.


In a pilot open-labeled study 10 subjects with AIDS dementia complex (ADC) were treated with didanosine. Only half of the subjects were able to complete the trial as a result of side effects. Five subjects exhibited improved performance on neuropsychological testing, but the mean change in performance in this small group was not statistically significant. The study suggests that this drug may have some value in ADC patients unable to tolerate other therapies, but that further study is needed to establish this firmly.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center